Click here for Dr. Salomon's Curriculum Vitae

CURRICULUM VITAE

Name: Daniel R. Salomon, M.D.

Office Address: Department of Molecular and Experimental Medicine – MEM241The Scripps Research Institute10550 North Torrey Pines RoadLa Jolla, CA 92037(858) 784-9381 FAX: 784-2121email: [email protected]

Born: January 27, 1953

Place: Boston, Massachusetts

Education: Northwestern UniversityEvanston, ILChemistry 1973

Stritch-Loyola School of MedicineMaywood, ILMedicine 1976

Internship: Cedars-Sinai Medical CenterLos Angeles, CA 1976-77

Residencies: Cedars-Sinai Medical Center 1977-79Chief Resident, Cedars-Sinai Medical Center

Los Angeles, CA 1979-80

Fellowship: Research Fellow in MedicineHarvard Medical School, Laboratory

of Immunogenetics and TransplantationBoston, MA 1980-82

Clinical Fellow in MedicineHarvard Medical School, RenalDivision, Brigham and Women'sHospital Boston, MA 1982-83

Senior Fellow in Medicine, HarvardMedical School, Laboratory ofImmunogenetics and TransplantationBoston, MA 1983-84

Employment/Academic Appointments:Assistant Professor of Medicine

University of Florida,Gainesville, FL 1984-1989

Associate Professor of Medicine (Tenure)University of Florida

Daniel R. Salomon, M.D. version: April 13, 2023 page 1

Gainesville, FL 1989-1990Clinical Associate Professor of Medicine

Georgetown University Medical CenterWashington, D.C. 1990-1993

Guest Researcher, Cellular Immunology SectionNIAID, National Institutes of Health 1990-1993

Assistant ProfessorDept. of Molecular and Experimental Medicine The Scripps Research Institute 1993-1998

Adjunct Associate Professor of MedicineUniversity of California, San Diego 1995-1999

Associate ProfessorDept. of Molecular and Experimental Medicine The Scripps Research Institute 1998-2006

Associate Professor with TenureDept. of Molecular and Experimental Medicine The Scripps Research Institute 2006-present

Positions: Medical Director, Renal Transplant Service 1984-1990University of Florida

Medical Director, Cardiac Transplant Program 1985-1990University of Florida

Director, Lab. of Transplantation Immunology 1984-1990University of Florida

Director, Transplantation ResearchDivision of Organ TransplantationThe Scripps Clinic and Research Foundation 1993-2000

Medical Director, Kidney/Pancreas Transplant Program, Scripps Center for Organ and Cell Transplantation 1996-present

Director, Core Laboratory, General Clinical Research Center (GCRC) 1998-2005

Co-Director, GCRC DNA Microarray Core Laboratory 2001-2005

Co-Director, Scripps Center for Organ and Cell Transplantation 2000-present

Director, TSRI Normal Blood Drawing Service 2005-presentDirector, TSRI Special Hematology Laboratory

CLIA-certified for Hematology and Genomics 2008-present

Honors and Awards: Leo Rigler Award “Intern of the Year”, Cedars-Sinai Medical Center 1977

Special Citation, State of Massachusettsfor Research in Transplantation 1984

ASN Travel Award to X International Congress 1987Robert Nakamura Lectureship, Scripps Clinic

and Research Foundation 2000


Scripps Green Hospital, Leadership in Program Development Award 2004

S. Mark Taper Lectureship, St. Vincent’sMedical Center, Los Angeles 2005

Alpha Omega Alpha Society, Elected Alumni Member and Visiting Professorship, Stritch School of Medicine, Maywood, IL 2007

Suren Sehgal Memorial LectureCanadian Society of Transplantation 2008

Societies (Current):American Society of Transplantation 1985-presentInternational Society of Transplantation 1999-presentXenotransplantation Society 1999-presentAmerican Society of Gene Therapy 2000-presentAmerican Society of Microbiology 2006-presentAlpha Omega Alpha Society 2008-present

Grants:

Division of Sponsored Research, New Faculty Support Program 1985-1986American Kidney Fund, Immunological Mechanisms in the

Pathogenesis of FSGS (Principal Investigator) 1986-1987National Institutes of Health, R01, Effect of Blood Transfusions

after Transplant Surgery (Co-Principal Investigator) 1987-1990Interdisciplinary Biotechnology Program Award 1988-1989National Institutes of Health, K08, Clinical Investigator Award,

Tolerance in Experimental Kidney Transplantation (Principal Investigator) 1988-1993

Multicenter Trial for Immunosuppression of Highly Sensitized Transplant Candidates, Sandoz 1990-1992

Scripps Clinic and Research Foundation, Intramural Clinical Research Xenotransplantation of pancreatic islets and thymic epithelial cells: T cell development and tolerance (Principal Investigator) 1995-1996

National Institutes of Health, R01, Complement Activation in Kidney Transplantation, Contract Study (Co-Investigator: Dr. T. Hugli) 1996-1998

Juvenile Diabetes Foundation International Grant; Intrathymic Islet Xenotransplantation in Non-Human Primates with Insulin-Dependent Diabetes Mellitus (Principal Investigator) 1996-1998

Juvenile Diabetes Foundation International, Career DevelopmentAward for Dr. Laura Crisa, The role of HLA-G, a non-polymorphic MHC Class I molecule, in tolerance induction for pancreatic islet transplantation in IDDM. 1997-2000

National Institutes of Health R01, Importance of Islet Structure in Islet Transplantation (Principal Investigator) 1997-2002

Telios/Integra Life Sciences, Using three dimensional templates coated with cyclic matrix- and integrin-specific adhesive site analogs to facilitate successful islet transplantation (Principal Investigator). 1997-2001


Genetic Therapy Incorporated (GTI)/Systemix/Novartis Pharma, Developing gene therapy-based strategies for allogeneic bone marrowtransplantation and xenotransplantation (Principal Investigator). 1998-2000

National Institutes of Health, General Clinical Research Center (GCRC),Director, Core Laboratory 1998-2005

National Institutes of Health R01, Xenogeneic infection risk with pig islet transplantation (Principal Investigator). 1999-2004

National Institutes of Health, R01, Alloreactivity to pancreatic islets: Modulation by HLA-G (P.I. Laura Crisa) 2000-2003

National Institutes of Health, R01 Bone Marrow Transplantation Clinical Network (P.I. Edward Ball) 2001-2005

National Institutes of Health, R01 Expression and function of the humanPERV-A receptor (Principal Investigator). 2002-2007

National Institutes of Health, R21 Lentiviral transduced endothelium forislet transplants (Principal Investigator). 2002-2004

MicroIslet, Alginate encapsulation for pig islet xenotransplantion(Principal Investigator) 2003-2007

MicroIslet, Pig islet encapsulation in diabetic Rhesus macaques(Principal Investigator) 2004-2007

National Institutes of Health, Program Project: U19 Genomics for Kidney Transplantation (Principal Investigator) 2004-present

Wyeth Pharmaceuticals, Gene expression and proteomic profiling of Chronic Allograft Nephropathy in Biopsies and PBL (Principal Investigator) 2005-2006

Roche Pharmaceuticals, Relationship between changes in peripheral blood lymphoid subsets and peripheral blood cell gene expression profiles in the early post transplant period in kidney transplant patients(Principal Investigator) 2006-2007

National Institutes of Health, R01 Liver Regeneration in the Transplant Setting(P.I. Kim Olthoff, University of Pennyslvania) 2006-present

National Institutes of Health, R01 Probing the Biochemical Mechanism ofAmyloid Disease (P.I. Jeff Kelly, TSRI) 2006-present

Roche Pharmaceuticals, Genomics Study of Liver Transplant Patients with Rejection and Recurrent HCV for STN Clinical Trial(Principal Investigator) 2006-2007

Cystinosis Research Foundation, Treatment of cystinosis nephropathy using genetically modified adult stem cells (Principal Investigator) 2006-present

National Institutes of Health, Conference Grant, First Scripps Workshopin Genomics for Transplantation, May 17-19, La Jolla, CA 2006

National Institutes of Health, R01 Expression and function of the human 2007-presentPERV-A receptor (Principal Investigator).

National Institutes of Health, Conference Grant, Second Scripps Workshopin Genomics for Transplantation, January 30-31, La Jolla, CA 2009

National Institute of Health, R01 MicroRNA regulation of human T and B cell activation (Principal Investigator) 2009-present

Special Activities:


Federal GovernmentDepartment of Health and Human Services (DHHS),

Chairman: Organ Procurement and TransplantationNetwork (OPTN) Contract Review 1993

Food and Drug Administration (FDA), Division of Cellular and Gene Therapies, Center for BiologicsEvaluation and Research: Ad Hoc Member, Planning for XenotransplantationConsensus and Public Health Guidelines 1995

Food and Drug Administration (FDA), Division of Cellular and Gene Therapies, Center for BiologicsEvaluation and Research: Special Government Employee (SGE) 1995-present

Food and Drug Administration (FDA), Division of Cellular and Gene Therapies, Center for BiologicsEvaluation and Research: Expert Trial Witness 1996

Food and Drug Administration (FDA), Division of Cellular and Gene Therapies, Center for Biologics,Xenotransplantation Advisory Sub-Committee 1997-2004

Food and Drug Administration (FDA), Division of Cellular and Gene Therapies, Center for Biologics,Biological Response Modifiers Advisory Comm. 1998-1999

Chair 1999-2003U.S. Secretary of Health’s Xenotransplantation

Advisory Committee 2000-2004National Institutes of Health, National Center for

Research Resources (NCRR), Islet Cell ResourceCenters Project

Chair, Steering Committee 2001-2006National Institutes of Health, Study Section:

Surgery, Anesthesia and Trauma/Transplantation 2003 - 2004National Institutes of Health, Study Section:

Transplantation, Tolerance and Tumor Immunology 2004-2007

National Institutes of Health, Genomics of Transplantation Cooperative Research Program Steering Committee (Chair) 2006-present

National Institutes of Health, National Eye InstituteData Safety Monitoring Committee for LCA GeneTherapy Trial 2007-present

Reviewer-Individual Grants/Study Sections (in addition to standing memberships):

American Heart Association, Florida Affiliate 1989National Kidney Foundation of Canada 1991National Kidney Foundation of Canada 1992National Science Foundation 1992Veterans Administration Medical Service 1992


National Kidney Foundation 1993University of Louisville Foundation 1994National Institutes of Health - National Cooperative Drug Discovery Groups

for the Treatment of HIV Infection. Member, Special Emphasis Panel 1995National Institutes of Health - Interdisciplinary Programs in Autoimmunity,

NIAID, Special Review Committee 1996University of Louisville Foundation 1996American Heart Association, Western Affiliate 1998National Institutes of Health – Ad Hoc Study Section

Program Projects in Transplantation Tolerance 1998American Heart Association, Western Affiliate 1999National Institutes of Health – Special Emphasis Panel (NIAID)

Stem cell transplantation for the treatment of autoimmune diseases 1999Food and Drug Administration – Laboratory Site Review

Laboratory of Cytokine Biology 1999Food and Drug Administration – Chair, Laboratory Site Review

Laboratory of Cytokine Research 1999Veterans Administration Merit Review Program – Grant Review 2000American Heart Association, Western Affiliate 2000The Wellcome Trust 2000National Institutes of Health Immune Tolerance Network (NIAID)

Grant Review – Nonhuman Primate Models for Tolerance 2000Medical Research Council (Great Britain)

Grant Review – Porcine Endogenous Retrovirus Infection and Biology 2000Veterans Administration Merit Review Program – Grant Review 2001American Heart Association, Western Affiliate, Co-Chair Section B 2001National Institutes of Health, National Center for Research Resources

Chair, Special Emphasis Panel - National Gene Vector Laboratories Program 2001

Veterans Administration Merit Review Program – Grant Review 2002American Heart Association, Western Affiliate, Co-Chair Section B 2002Swiss National Science Foundation

Grant Review – Islet xenotransplantation in the pig to nonhumanPrimate model 2002

Food and Drug Administration – Chair, Laboratory Site ReviewLaboratory of Molecular Tumor Biology and Laboratory of of Gene Regulation 2002

National Institutes of Health, NIDDK, Special Emphasis PanelInnovative Partnerships in Type I Diabetes Research 2002

National Institutes of Health, Study Section: Ad Hoc, Surgery, Anesthesia and Trauma/Transplantation 2002

National Institutes of Health, NHLBI, Special Emphasis PanelProgram Project in Transplantation Tolerance 2003

National Institutes of Health, NHLBI, Special Emphasis PanelProgram Project in Transplantation Tolerance 2004

National Institutes of Health, NIDDK, Special Emphasis PanelXenogeneic Bioartificial Liver 2005

Foundation Fighting Blindness, Grant Review: Genotyping Microarrays for Retinitis Pigmentosa 2005


Genome Canada, Grant Review 2006National Institutes of Health, Study Section:

Ad Hoc, Transplantation, Tolerance and Tumor Immunology 2008National Institutes of Health, Study Section:

Special Emphasis Panel: Program Project in Transplantation Outcomes 2008National Institutes of Health, NIDDK, Study Section (Ad Hoc):

Kidney and Urology 2009National Institutes of Health, NIAID, Study Section (Ad Hoc):

Transplantation, Tolerance, and Tumor Immunology 2009National Institutes of Health, NHLBI, Special Emphasis Panel:

Program Project in Blood Stem Cell Transplantation as Immunotherapy 2009Roche Organ Transplant Research Foundation 2009

PhD Thesis Committees:

Scott Todd, Issues Related to the Expression of CD21 on Human Thymocytes. San Diego State University, Dept. of Biology 1995-1996

Olgun Guvench, M.D., Theoretical Studies of Protein and Protein-ligand Structures by Computational Biology, TSRI 2001-2005

Andrew Ward, Molecular Mechanism of Substrate Translocation in ABC Transporters, TSRI 2004-2008

Katie Marcucci, Viral Late Domains in PERV Virion Assembly, TSRI(Graduate Advisor) 2004-2008

Yevgeniy Grigorev, Genomics of Human Lymphocyte Activation, TSRI(Graduate Advisor) 2006-present

Anke Mulder, To be titled, TSRI 2006-presentMiller Tran, To be titled, TSRI 2008-presentKatie Podshivalova, To be titled, TSRI 2008-present

Activities in Support of Institutional and Societal Objectives:

Intramural University of Florida:

Renal Transplant Review Board 1984-1990Cardiac Transplant Review Board 1985-1990Chairman, Department of Medicine Computer Committee 1988-1990Ad hoc Computer Steering Committee, University Physicians 1989-1990Member, Operational Systems Coordinating Committee 1989-1990

Scripps Clinic and Scripps Health:Department of Academic Affairs

Research Study Section 1994-2002Division of Quality Assurance, Clinical Practice


Review Committee 1997-1999Organ Transplantation Review and Advisory Committees 1993-2004Medical Director, Kidney Transplantation 1993-presentTransplantation Finances Executive

Committee 2001-2004Co-Director, Scripps Center for Organ and

Cell Transplantation 2004-present

The Scripps Research Institute:General Clinical Research Center Advisory Committee 1993-1998General Clinical Research Center

Executive Board 1998-2005Faculty, Graduate Program in Chemical

and Biological Sciences 1999-presentGraduate Course Director - Molecular Medicine 2004-presentGraduate Program Admissions Committee 2005-present

ExtramuralEditorial Boards:

The Journal of Heart and Lung Transplantation 1986-2000Philippine Journal of Nephrology 1992-1995Graft 1998-2002Current Opinion in Anti-inflammatory and

Immunomodulatory Drugs 1998-2004Indian Journal of Nephrology 2000-2002PreClinica 2002-2005 Transplantation 1992-presentAmerican Journal of Transplantation

Associate Editor 2005-present

Professional Societies:North Central Florida Kidney Foundation

Advisory Board Co-Chairman, Education 1986-1988American Society of Transplantation:

Ethics Committee 1987UNOS Committee 1988-1989Chair, Extrarenal Transplant Committee 1989-1991Intrathoracic Organ Committee 1991-1994

Program Committee 1987-1993 Co-Chair 1990-1991 Chair 1991-1993

Co-Chair, Genomics and Proteomics 2005Reviewer, World Transplant Congress 2006Reviewer/Chair for Proteomics/Genomics 2007Reviewer/Chair for Proteomics/Genomics 2008Reviewer, Cell Transplantation and


Bioengineering 2009Scientific Studies Committee 1993-1995Executive Council 1995-1998Government Relations Committee 1995-1997AST Internet/WWW Site

Development Committee 1995-1998Co-Web Master 1997-1998

CenterSpan ProjectTreasurer, Executive Board 1995-1998

Xenotransplantation CommitteeChair 1996-1998

Ad Hoc, Cell Transplantation CommitteeChair 2003-2006

Ad Hoc, Reimbursement Committee 2005-presentAmerican Society of Transplant Surgeons

Co-Founder and Co-Moderator of CenterSpanL Listserve 1998-present

International Society of Heart and Lung Transplantation Program Committee Co-chair, Immunosuppression Sub-Committee 1992-1993Co-chair, Immunobiology Sub-Committee 1993-1994Program Committee, Abstract Reviews 2004

National Kidney Foundation, National Capital Area:Research Committee 1992-1993

National Kidney Foundation:Program Committee

Chair, Transplantation and PediatricNephrology, 1996 National MeetingNew Orleans, LA 1995-1996

NKF cyberNephrology Initiative 1997-1999 International Society of Nephrology

ISN Commission on Nephrology Informatics 1997-1999 Xenotransplantation SocietyProgram Committee, 4th International CongressNantes, France 1997

International Transplantation SocietyProgram Committee, XVII World Congress Montreal, Canada 1998Program Committee, XIX International Congress Buenos Aires, Argentina 2002Program Committee, XX International Congress Vienna, Austria 2004Program Committee, XXII International Congress Sydney, Australia 2008

American Heart AssociationWestern States AffiliatePeer Research Review Committee (South B) 1997-1999Vice-Chair, Review Committee (South B) 2000-2002Chair, Review Committee (South B) 2002-2004


Member, AHA Scientific Advisory Board 2001-2005American Society of Gene Therapy

Committee on Clinical and Regulatory Affairs 2003-2004Chair 2004-2006

Committee on Public Education 2005-2007

Consultant/Advisory Boards:Consultant/Lecturer: Washington Hospital Center

Kidney Transplant Program 1990-1993Sandimmune Retrospective Study Group 1990-1992Medical Consultant: Cyclosporine G - Multicenter

New Drug Trial (Sandoz) 1990-1995Chair, Data Safety Monitoring Board 1993-1995

Cyclosporine G - National Advisory Panel 1991-1995Medical Consultant and Safety Officer:

Data Coordinating Center - NIH, NIAID, DAIT Cooperative Clinical Trials inTransplantation (CCTT, CCTAT, CCTPT) 1991-2001

Consultant: Multicenter Photopheresis Trial in Cardiac Transplantation, Therakos Inc. 1994-1997

Data Safety Monitoring Board, Mycophenolate MofetilPivotal Trial in Cardiac Transplantation, Hoffman La Roche Pharmaceuticals 1994-1996

Clinical Investigator, The UVAR Photopheresis Systemin Conjunction with Uvadex for the Treatment ofRecalcitrant Kidney Allograft Rejection: An OpenLabel Study, Therakos Inc. 1995-1996

International Clinical Advisory Board in Xenotransplantation, Novartis Pharmaceuticals 1996-2000

Medical Consultant, Neoral Global Database ProjectTeam, Novartis Pharmaceuticals 1997-2000

Board of Directors, Centre for Human Development 1998-2001Consultant, Human Organ Sciences 1998Medical Consultant and Safety Officer:

Data Coordinating Center – NIH Immune Tolerance Network in Transplantation, Allergy and Autoimmunity 1999-2001

Maxygen, Consultant in Safety and Clinical Trialsfor Therapeutic Gene Delivery 2001-2003

Scientific Advisory Board, Cythera 2001-2005Scientific Advisory Board, Genetics Therapy Inc.,

Novartis 2002Scientific Advisory Board, Microislets Inc.

Chair 2001-2007Scientific Advisory Board, Intronn Inc. 2002-2005Scientific Advisory Board, Celladon Inc. 2005-2007Consultant, Rigel Pharmaceuticals Inc. 2005-2007NIDDK Transplant Surgery Scientist Training

Program (T32), Northwestern University


P.I. Dr. Michael AbecassisExternal Members Oversight Committee 2007-present

CUPID Trial of AAV Gene Therapy, Data SafetyMonitoring Board, Celladon Inc. 2007-present

Efaluzimab in Kidney Transplantation, Data SafetyMonitoring Board, Kenneth Newell, EmoryUniversity 2008-present

International:Health Canada, Consultant,

National Forum on Xenotransplantation 1997

Medical License: California #G38117 1978-801993-present

Massachusetts #74385 1980Florida #47401 1984

BIBLIOGRAPHY

Papers

1. Salomon DR, Cohen DJ, Carpenter CB and Milford EL: Regulation of the immune response to alloantigens: Suppressor and helper T cells generated in the primary MLR of the rat. Jorunal of Immunology, 131:1065-1072,1983.

2. Salomon DR, Cohen DJ, Williams J and Carpenter CB: Feedback suppression of primary rat MLR cannot be bypassed by exogenous interleukin-2. Transplantation Proceedings, XV: 1654-1655, 1983.

3. Salomon DR, Cohen D, Williams J, Milford EL and Carpenter CB: Feedback suppression of proliferation and differentiation in rat MLR by OX8+ antigen-specific Ts. Transplantation Proceedings, XV:774-776, 1983.

4. Salomon DR, Cohen DJ, Williams J and Carpenter CB: T cell synergy in the primary MLR: Proliferative kinetics, effector cell generation and IL-2 production. Journal of Immunology, 133:1-9, 1984.

5. Salomon DR, Carpenter CB, Uhteg LC, Rocher LL and Kupiec JW: Cyclosporine-induced transplantation tolerance: Analysis of two populations of suppressor cells. Transplantation Proceedings, XVII:1336, 1985.

6. Uhteg LC, Salomon DR, Rocher LL, Rubin M and Carpenter CB: Suppressor and helper T cells traffic in distinct kinetic patterns through the lymphoid compartments of the cyclosporine treated cardiac allografted rat. Transplantation Proceedings, XVII: 861, 1985.


7. Uhteg LC, Salomon DR, Rocher LL, Kupiec JW, Tilney NL and Carpenter CB: Mechanism of cyclosporine induced transplantation tolerance studied by in vitro assays of helper and suppressor T cells. Journal of Immunology, 135(3):1800-5, 1985.

8. Conti CR, Salomon DR and Carmichael MC: Cardiac Transplantation, Journal of the Florida Medical Association, 13(2):111-113, 1986.

9. Uhteg LC, Kupiec-Weglinski JW, Rocher LL, Salomon DR, Tilney NL and Carpenter CB: Systemic Natural Killer Activity Following Cardiac Engraftment in the Rat: Lack of correlation with graft survival. Cellular Immunology, 100(1):274-279, 1986.

10. Lee TH, Salomon DR, Rayment C and Antman EM: Hypotension and Sinus Arrest with Exercise-induced Hyperkalemia and Combined Verapamil-Propranolol Therapy. Annals of Internal Medicine, 80:1203-1204, 1986.

11. Carmichael MJ, Salomon DR and Sadler LA: Cardiac Transplantation: The first year's experience at the University of Florida-Shands Hospital. Journal of the Florida Medical Association, 3(11):849-854, 1986.

12. Milford EL, Carpenter CB, Kirkman RL, Tilney NL, Mazoujian G, Strom TB, Lazarus JM, Schlossman SF, Guttmann RD, Lowry R, Rocher L, Cambell Jr. DA, Salomon DR and Pfaff WW: Anti-T12 monoclonal antibody therapy of acute renal allograft rejection. Transplantation Proceedings, XIX(1):1182-1183, 1987.

l3. Scornik JC, Ireland JE, Salomon DR, Howard RJ, Fennell RS III and Pfaff WW: Pretransplant blood transfusions in patients with previous pregnancies. Transplantation, 43(3):449-451, 1987.

14. Salomon DR, Boerth LW, Rocher LL, and Pennington JE: Quantitative and functional evaluation of alveolar macrophages in the cyclosporine-treated host. In Infections in Transplant Patients, edited by Hartmuthode, Dieter Huhn and Martin Molzahn, George Thieme Verlag Stuttgart, pp. 193-203, 1987.

15. Locke DR, Steinbock G, Salomon DR, Bezirdjian L, Peterson J, Newman RC, Hawkins IF, Kauder J and Finlayson B. Combination extracorporeal shock wave lithotripsy and percutaneous extraction of calculi in a renal allograft. Journal of Urology, 139(3):575-577, 1988.

16. Uhteg LC, Salomon DR, Cohen DJ, Cramer DV and Carpenter CB: Characterization of the Ia antigens involved in suppressor T cell generation in the rat. Immunogenetics, 26(3):138-143, 1987.

17. Scornik JC, Salomon DR, Howard RJ and Pfaff WW: Evaluation of antibody synthesis in broadly sensitized patients. Transplantation, 45(1):95-101, 1988.

18. Wynn JJ, Pfaff WW, Patton PR, Peterson JC, Salomon DR, Fennell RS, Scornik JC and Howard RJ: Late results of renal transplantation. Transplantation, 45(2):329-333, 1988.


19. Dunbar KR, Salomon DR, Kaude J, Wingo CS, Peterson JC, Croker BP, Thompson RD and Tisher CC: Loss of corticomedullary demarcation on magnetic resonance imaging: An index of biopsy-proven acute renal transplant dysfunction. American Journal of Kidney Disease, 12(3):200-207, 1988.

20. Weir MR, Salomon DR, Cohen DJ and Carpenter CB: Lack of secondary suppressor response in enhanced allografted rats with endogenous suppressor activity in spleen and diminished cytotoxic T cell response. Transplantation, 46(5):731-739, 1988.

21. Pfaff WW, Howard RJ, Scornik JC, Day C, Renderer J, Scott J, Fennell RS, Peterson JC, Salomon and Patton PR: Incidental and purposeful random donor blood transfusions: Sensitization and Transplantation. Transplantation, 47(1):130-133, 1989.

22. Scornik JC, Salomon DR, Howard RJ and Pfaff WW: Prevention of transfusion-induced broad sensitization in renal transplant candidates. Transplantation, 47(4):617-621, 1989.

23. Scornik JC, Salomon DR, Lim PB, Howard RJ and Pfaff WW: Post-transplant anti-donor antibodies and graft rejection. Evaluation by two-color flow cytometry. Transplantation, 47(2):287-290, 1989.

24. Patton PR, Howard RJ, Pfaff WW, Wynn JJ, Fennell RS, Finlayson B, Newman RC, Peterson JC, Salomon DR and Scornik JC: Renal Transplantation: A Twenty Year Experience at the University of Florida 1966-1985. Southern Medical Journal, 82(11):1334-1343, 1989.

25. Howard RJ, Pfaff WW, Salomon DR, Peterson JC, Scornik JC and Frederickson ED, Fennell RS, III: Kidney Transplantation in older patients. Transplantation Proceedings, 21(1):2020-2021, 1989.

26. Howard RJ, Pfaff WW, Scornik JC, Salomon DR, Peterson JC, and Brunson ME: Kidney transplantation in older patients. Clinical Transplantation, 4:181-186, 1989.

27. Squiers E, Salomon DR, Howard R and Pfaff W: Studies on tolerance phenomenon from portal vein exposure of antigen I: Abrogation of tolerance induction by inhibition of Kupffer cell phagocytosis. Transplantation, 50:171-174, 1990.

28. Salomon DR, Brunson ME, VanSickler J, Pfaff W, Howard R, Peterson J, Curry T, Thompson R and Squiers E: Retrospective Analysis of Late Renal Graft Function: A correlation with mean cyclosporine levels and lack of evidence for chronic cyclosporine toxicity. Transplantation Proceedings, 23:1018-1019, 1991.

29. Van Sickler JT, Salomon DR and Pickard LL: Suppressor cells and T cell synergy in the primary MLR: Interleukin-2 is required for maintenance of Rat CD8+ suppressor cells. Cellular Immunology, 134:390-401, 1991.

30. Scornik JC, Salomon DR, Fennell RS, Howard RJ and Pfaff WW: Evaluation of immuno-suppression as a treatment for pre-sensitization in renal candidates. Clinical Transplantation, 5:121-125, 1991.


31. Norman S, Salomon DR, Leelachaikul P, Khan SR, Staples E, Alexander JA, Mayfield WR, Knauf DG, Sadler LA and Selman S: Acute coronary vascular rejection in cardiac transplantation: Pathology and correlations with CMV infection and immunosuppressive protocols. Journal of Heart Transplantation, 10:674-687, 1991.

32. Salomon DR: An alternative view minimizing the significance of cyclosporine nephro-toxicity and in favor of enhanced immunosuppression for long term kidney transplant recipients. Transplantation Proceedings 23(4):2115-2118, 1991.

33. Norman S, Khan SR, Leelachaikul P, Salomon DR: The origin of the infiltrating cells in the proliferative coronary initimal lesion of acute vascular rejection in human heart transplants. Journal of Heart Transplantation, 11:492-499, 1992.

34. Squiers EC, Brunson ME and Salomon DR: Kupffer cells can present alloantigen in vitro: An effect abrogated by gadolinium. Journal of Surgical Research 55(6):571-574, 1993.

35. Solez K, Axelson RA, Banner B, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, Croker BP, Droz D, Dunnill MS, Halloran PF, Hayry P, Jennette JC, Keown PA, Marcussen N, Mihatsch MJ, Myers BD, Nast CC, Olsen S, Racusen LC, Ramos EL, Rosen S, Sachs DH, Salomon DR, Sanfilippo F, Verani R and von Willebrand E. International Standardization of Nomenclature and Criteria for the Histological Diagnosis of Renal Allograft Rejection: The Banff Classification of Kidney Transplant Pathology. Kidney International, 44:411-422, 1993.

36. Burke JF, Pirsch JD, Ramos EL, Salomon DR, Stablein DM, Van Buren DH and West JC. A Multicenter Four-Year Retrospective Study of Renal Transplant Recipients Treated with Cyclosporine: Evidence for Long-Term Efficacy and Safety. New England Journal of Medicine, 331(6):358-363, 1994.

37. Salomon DR, Chang AC, Mojcik CF, Wadsworth S, Adams DH, Coligan JE and Shevach EM. Constitutive activation of integrin 4ß1 defines a unique stage of human thymocyte development. Journal Experimental Medicine, 179:1573-1584, 1994.

38. Beattie GM, Levine F, Mally MI, Otonski T, O’Brien JS, Salomon DR and Hayek A. Acid ß-galactosidase: A developmentally regulated marker of endocrine cell precursors in the human fetal pancreas. J. Clinical Endocrinology and Metabolism, 78:1232-1240, 1994.

39. Chang AC, Salomon DR, Wadsworth S, Mojcik CF, Shevach EM and Coligan JE. Adhesion and costimulation of proliferative responses of human thymocytes by the interaction of 3ß1 and 6ß1 integrins with laminin and merosin. Journal of Immunology, 154: 500-510, 1995.

40. Goto S, Salomon DR, Ikeda Y and Ruggeri ZM. Characterization of the unique mechanism mediating shear-dependent binding of soluble von Willebrand factor to platelets. Journal of Biological Chemistry, 270: 23352-23361, 1995.

41. Mojcik CF, Salomon DR, Chang AC and Shevach EM. Differential expression of integrins on human thymocyte subpopulations. Blood, 86: 4206-4217, 1995.


42. Chapman LE, Salomon DR, Patterson AP, Eggerman TL, Noguchi PD and Folks TM. Xenotransplantation and xenogeneic infection. New England Journal of Medicine, 333: 1498-1501, 1995.

43. Normann SJ, Peck AB, Staples ED, Salomon DR and Mills RM. Experimental and clinical allogeneic cardiac transplant rejection: Correlations between histology and immune reactivity detected by cytokine messenger RNA. Journal of Heart and Lung Transplantation, 15:778-789, 1996.

44. Salomon DR. Beyond Rejection and Infection: The challenge of cell biology to xenotransplantation. Journal of Molecular Diagnosis, 1:235-237, 1996.

45. Crisa L, Cirulli V, Ellisman MH, Ishii JK, Elices MJ and Salomon DR. Cell adhesion and migration are regulated at distinct stages of thymic T cell development: the roles of fibronectin, VLA4 and VLA5. Journal of Experimental Medicine, 184:215-228, 1996.

46. Salomon DR, Crisa L, Mojcik CF, Ishii JK, Klier G and Shevach EM.Vascular cell adhesion molecule-1 is expressed by cortical thymic epithelial cells and mediates thymocyte adhesion: Implications for the function of (VLA4) integrin in T-cell developmentBlood, 89: 2461-2471, 1997.

47. Cramer DV, Wu GD, Chapman FA, Marboe C and Salomon DR. 2-Chlorodeoxyadenosine in combination with cyclosporine inhibits the development of transplant arteriosclerosis in rat cardiac allografts. Transplantation Proceedings, 29:616, 1997.

48. Todd SC, Lipps SG, Crisa L, Salomon DR and Tsoukas CD. CD81 expressed on human thymocytes mediates integrin activation and IL2-dependent proliferation. Journal of Experimental Medicine, 184:2055-2060, 1997.

49. Cooperative Clinical Trials in Transplantation Research Group. Murine OKT4a immunosuppression in cadaver donor renal allograft recipients. Transplantation, 63:1243-1251, 1997.

50. Crisa L, McMaster MT, Ishii JK, Fisher SJ and Salomon DR. Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. Journal of Experimental Medicine, 186:289-298, 1997.

51. Colvin RB, Cohen AH, Saiontz C, Bonsib S, Buick M, Burke B, Carter S, Cavallo T, Haas M, Lindblad A, Manivel JC, Nast CC, Salomon DR, Weaver C and Weiss M. Evaluation of pathological criteria for acute renal allograft rejection: Reproducibility, sensitivity and Clinical correlation. Journal of American Society of Nephrology, 8:1930-1941, 1997.

52. Zaitseva MB, Mojcik CF, Salomon DR, Shevach EM and Golding H. Co-ligation ofintegrin and TCR rescues human thymocytes from steroid-induced apoptosis. International Immunology, 10:1551-1561, 1998.

53. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro M-C, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman


EO, Hunsicker LG, Lindblad A, Marcussen N, Mihatsch MJ, Nadasdy T, Nickerson P, Olsen TS, Papadimitriou JC, Randhawa PS, Rayner DC, Roberts I, Rose S, Rush D, Salinas-Madrigal L, Salomon DR, Sund S, Taskinen E, Trpkov K and Yamaguchi Y. The Banff ‘97 working classification of renal allograft pathology. Kidney International, 55:713-723, 1999.

54. Crisa L, Cirulli V, Smith KA, Ellisman MH, Torbett BE and Salomon DR. Human cord blood progenitors sustain thymic T cell development and a novel form of angiogenesis. Blood, 94:3941-3946, 1999.

55. Hsu DK, Yang R, Pan Z, Yu L, Salomon DR, Fung-Leung WP and Liu FT. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. American Journal of Pathology, 156:1073-1083, 2000.

56. Cirulli V, Beattie GM, Klier G, Ellisman M, Ricordi C, Quaranta V, Frasier F, Hayek A and Salomon DR. Expression and function of avb3 and avb5 integrins in the developing pancreas: roles in the adhesion and migration of putative endocrine progenitor cells. Journal of Cell Biology, 150:1445-1460, 2000.

57. Van der Laan LJW, Lockey C, Griffeth BC, Frasier FS, Wilson CA, Onions DE, Hering BJ, Long Z, Otto E, Torbett BE and Salomon, DR. Infection by porcine endogenous retrovirus after islet transplantation in SCID mice. Nature, 407: 90-94, 2000.

58. Pelletier AJ, van der Laan L, Siani MA, Thompson DA, Torbett BE and Salomon DR. Presentation of Chemokine SDF-1 by Fibronectin Mediates Directed Migration of T Cells. Blood, 96: 2682-2688, 2000.

59. Rubin RL, Salomon DR and Guerrero RS. Thymus function in drug-induced lupus. Lupus 10:795-801, 2001.

60. Salomon DR. Conclusions: The Second Cabo Gene Therapy Working Group. Cabo II, Immunology and Gene Therapy, Molecular Therapy, 5(5):486-491, 2002.

61. Hayashi J, Salomon DR and Hugli TE. Elevated kallikrein activity in plasma from stable liver transplant recipients. International Immunopharmacology, 2:1667-1680, 2002.

62. Chismar JD, Mondala T, Fox H, Roberts E, Salomon DR and Head SR. Analysis of result variability from high-density Affymetrix oligonucleotide arrays comparing same-species (human/human) and cross-species (human/monkey) hybridizations. BioTechniques, 33: 516-524, 2002.

63. Ritzhaupt A, van der Laan LJW, Salomon DR, and Wilson CA. Porcine Endogenous Retrovirus (PERV) infects but does not replicate in non-human primate primary cells and cell lines. Journal of Virology, 76:11312-11320, 2002.

64. Ericsson TA, Takeuchi Y, Templin C, Quinn G, Farhadian SF, Wood JC, Oldmixon BA, Suling KM, Ishii JK, Salomon DR, Kitagawa Y, Miyazawa T, Weiss RA and Patience C. Identification of receptors for pig endogenous retrovirus. Proceedings National Academy of Sciences, 100(11):6750-6764, 2003.


65. Flechner SM, Kurian SM, Head SR, Sharp SM, Whisenant TC, Zhang J, Chismar JD, Horvath S, Mondala T, Gilmartin T, Cook DJ, Kay SA, Walker JR and Salomon DR. Acute Kidney Transplant Rejection and Tissue Injury Revealed in Gene Profiling Signatures of Biopsies and Peripheral Blood Lymphocytes. American Journal of Transplantation, 4(9):1475-89, 2004.

66. Hildbrand P, Cirulli V, Smith K, Torbett BE, Salomon DR and Crisa L. Angiopoietins regulate a stepwise development of endothelial cells from cord blood CD34+ progenitors. Blood, 104(7):2010-9, 2004.

67. Kunicki TJ, Salomon DR, Koziol J, Head SR, Mondala TS, Chismar JD, Baronciani L, Canciani MT and Federici AB. An association of integrin gene haplotypes and bleeding severity in Von Willebrand Disease (VWD) type 1 pedigrees. Blood, 104(8):2359-67, 2004.

68. Flechner SM, Kurian SM, Solez K, Cook DJ, Burke JT, Rollin H, Hammond JA, Whisenant TC, Lanigan CM, Head SR and Salomon DR. De novo kidney transplantation without use of calcineurin inhibitors preserves renal function and histology at two years. American Journal of Transplantation, 4(11):1776-85, 2004.

69. Flechner SM, Lanigan CM, Burke JT, Solez K and Salomon DR. Letter to the Editor and Additional Analysis: De Novo Kidney Transplantation Without Use of Calcineurin Inhibitors Preserves Renal Structure and Function at 2 Years. American Journal of Transplantation, 5:1169, 2005.

70. Cherqui S, Kurian SM, Schussler O, Hewel JA, Yates III JR and Salomon DR. Isolation, angiogenesis and proteogenomic profiling of endothelial progenitors in the fetal liver. Stem Cells, 24: 44-54, 2006.

71. Martina Y, Kurian SM, Cherqui S, Evanoff G, Wilson C and Salomon DR. Pseudotyping of Infectious Porcine Endogenous Retrovirus Species by Xenotropic Murine Leukemia Virus in a Pig Islet Xenotransplantation Model. American Journal of Transplantation, 8:1837-47, 2005.

72. Kunicki TJ, Baronciani L, Canciani MT, Gianniello F, Head SR, Mondala TS, Salomon DR and Federici AB. An association of candidate gene haplotypes and bleeding severity in von Willebrand Disease (VWD) type 2A, 2B and 2M pedigrees. Journal of Thrombosis and Hemostasis, 4(1):137-47, 2006.

73. Gemeniano M, Mpanju O, Salomon DR, Eiden MV and Wilson CA. The infectivity and host range of the ecotropic porcine endogenous retrovirus, PERV-C, is modulated by residues in the C-terminal region of its surface envelope protein. Virology, 346(1):108-17, 2006.

74. Martina Y, Marcucci K, Szabo A, Drysdale T, Wilson C, Patience C and Salomon DR. Mice transgenic for a human Porcine Endogenous Retroviral receptor are susceptible to productive viral infection. Journal of Virology, 80(7):3135-46, 2006.


75. Cirulli V , Zalatan J, McMaster M, Prinsen R, Salomon DR, Ricordi C, Torbett BE, Meda

P, Crisa L. The Class I HLA Repertoire of Pancreatic Islets Comprises the Nonclassical Class Ib Antigen HLA-G. Diabetes, 55(5):1214-22, 2006.

76. Niculescu AB, Lulow LL, Ogden CA, Le-Niculescu H, Salomon DR, Schork NJ, Caligiuri MP, Lohr JB. PhenoChipping of psychotic disorders: a novel approach for deconstructing and quantitating psychiatric phenotypes. American Journal of Medical Genetics and Neuropsychiatric Genetics, 141(6):653-62, 2006.

77. Cherqui S, Thorpe C, Kurian SM and Salomon DR. Lentiviral gene delivery of vMIP-II to transplanted endothelial cells and endothelial progenitors is proangiogenic in vivo. Molecular Therapy 15(7):1264-72, 2007.

78. Kurian SM, Flechner SM, Kaouk J, Modlin C, Goldfarb D, Cook DJ, Head S and Salomon DR. Laparoscopic donor nephrectomy gene expression profiling reveals upregulation of stress and ischemia associated genes compared to control kidneys. Transplantation, 80(8):1067-71, 2007.

79. Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, Campbell PM, Cascalho M, Collins AB, Demetris AJ, Drachenberg CB, Gibson IW, Grimm PC, Haas M, Lerut E, Liapis H, Mannon RB, Marcus PB, Mengel M, Mihatsch MJ, Nankivell BJ, Nickeleit V, Papadimitriou JC, Platt JL, Randhawa P, Roberts I, Salinas-Madriga L, Salomon DR, Seron D, Sheaff M and Weening JJ. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). American Journal of Transplantation, 7(3):518-26, 2007.

80. Flechner SM, Godfarb D, Solez K, Modlin CS, Mastroianni B, Savas K, Babineau D, Kurian SM, Salomon DR, Novick AC and Cook DJ. Kidney transplantation with Sirolimus and Mycophenolate Mofetil–based immunosuppression: 5-Year results of a randomized prospective trial compared to calcineurin inhibitor drugs. Transplantation, 83(7):883-892, 2007.

81. Hermida M, Domenech N, Moscoso I, Diaz T, Ishii J, Salomon DR and Mañez R. Lack of Cross-species transmission of Porcine Endogenous Retrovirus (PERV) to transplant recipients and abattoir workers in contact with pigs. Transplantation, 84(4):548-550, 2007.

82. Le-Niculescu H, McFarland MJ, Mamidipalli S, Ogden CA, Kuczenski R, Kurian SM, Salomon DR, Tsuang MT, Nurnberger Jr JI and Niculescu AB. Convergent functional genomics of bipolar disorder: From animal model pharmacogenomics to human genetics and biomarkers. Neuroscience & Biobehavioral Reviews, 31(6):897-903, 2007.

83. Marcucci KT, Martina Y, Harrison F and Salomon DR. Function of the two L domains of Porcine Endogenous Retrovirus: PPPY is dominant in viral release and structure but P(F/S)AP impacts viral maturation and infectivity. Virology. 2008 Jun 5;375(2):637-45.

84. Le-Niculescu H, Kurian SM, Yehyawi N, Dike C, Patel SD, Edenberg HJ, Tsuang MT, Salomon DR, Nurnberger Jr JI and Niculescu AB. Identifying blood biomarkers for mood disorders using convergent functional genomics. Molecular Psychiatry 14 (2):156-74, 2009.


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Citation&term=%22Cirulli+V%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Citation&term=%22Crisa+L%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Citation&term=%22Meda+P%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Citation&term=%22Meda+P%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Citation&term=%22Torbett+BE%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Citation&term=%22Ricordi+C%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Citation&term=%22Salomon+DR%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Citation&term=%22Prinsen+R%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Citation&term=%22McMaster+M%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Citation&term=%22Zalatan+J%22%5BAuthor%5D

85. Edemir B, Kurian SM, Eisenacher M, Lang D, Muller-Tidow C, Gabriels G, Salomon DR and Schlatter E. Activation of counter-regulatory mechanisms in a rat renal acute rejection model. BMC Genomics 9 (71): 1-34, 2008.

86. Osborn O, Brownell SE, Sanchez-Alavez M, Salomon DR, Gram H, Bartfai, T. Treatment with an Interleukin 1 beta antibody improves glycemic control in diet induced obesity. Cytokine 44 (1):141-8, 2008.

87. Takele A, Mariel F, Salomon DR, and Wilson CA. Identification of residues outside of the receptor binding domain that influence infectivity and tropism of porcine endogenous retrovirus. Journal of Virology 82 (15):7483-91, 2008.

88. de Jonge J, Kurian S, Shaked A, Salomon DR and Olthoff KM. Molecular networks of hepatic regeneration and metabolism in human living and deceased donor liver transplants. (in press and ON LINE, American Journal of Transplantation)

89. Hummel M, Kurian SM, Lin S, Borodyanskiy A, Zhang Z, Li Z, Kim SJ, Salomon DR, and Abecassis M. Intragraft TNF receptor signaling contributes to activation of innate and adaptive immunity in a renal allograft model. Transplantation 87(2):178-88, 2009.

90. Marcucci KT, Argaw T, Wilson CA and Salomon DR. Identification of two distinct structural regions in a human porcine endogenous retrovirus receptor, HuPAR2, contributing to function for viral entry. Retrovirology Jan 6:3, 2009.

91. Schussler O, Coirault C, Louis-Tisserand M, Al-Chare W, Oliviero P, Menard C, Michelot R, Bochet P, Salomon DR, Chachques JC, Carpentier A and Lecarpentier Y. Use of arginine–glycine–aspartic acid adhesion peptides coupled with a new collagen scaffold to engineer a myocardium-like tissue graft. Nature Clinical Practice Cardiovascular Medicine 6 (3):240-9, 2009.

92. Syres K, Harrison F, Jester JV, Simpson J, Roy S, Salomon DR, and Cherqui S. Successful treatment of cystinosis using bone marrow cell transplantation (In review, Blood)

93. Kurian SM, Heilman R, Mondala T, Nakorchevsky A, Hewel J, Campbell D, Robison E, Wang L, Gaber L, Solez K, Shidban H, Mendez R, Schaffer R, Fisher J, Flechner S, Head S, Horvath S, Yates J, Marsh C and Salomon DR. Biomarkers for Early and Late Stage Chronic Allograft Nephropathy by Proteogenomic Profiling of Peripheral Blood. (In review, PLOS One)

94. Grigoryev YA, Kurian SM, Campbell D, Head SR, and Salomon DR. Genome Wide Analysis of Immune Activation in Human T and B Cells Reveals Distinct Classes of Alternatively Spliced Genes. (In preparation)

Books

1. Salomon DR, Editor: New Immunosuppressive Agents II: Peptides, Adhesion Molecules and Monoclonal Antibodies in Transplantation, BioLiterature Inc., Chicago, IL, 1995.


2. Salomon DR and Wilson C, Editors: Xenogeneic Infection and Xenotransplantation, Current Topics in Immunology and Microbiology, Springer-Verlag, Berlin, 2003.

3. Marsh C and Salomon DR, Editors: Kidney Transplantation, Current Opinion in Organ Transplantation, Lippincott Williams & Wilkins, London, GB, 2006.

Chapters and Reviews

1. Salomon DR and Mitch W: Therapy of Renal Osteodystrophy and the Mineral Abnormalities of Chronic Renal Failure. In: Contemporary Issues in Nephrology, Chapter ll, edited by Brenner and Stein, Churchill Livingstone, Edinburgh, UK, 1984.

2. Russell SW and Salomon DR: Macrophage effector and regulatory functions. In: Immunity to Cancer, edited by AE Reif and MS Mitchell. Academic Press, 1984.

3. Salomon DR and Strom TB: Diagnosis and therapy of renal transplant rejection. In: Renal Transplantation , edited by M Garavoy and R Guttmann, Churchill Livingstone, Edinburgh, UK, pp. 125-157, 1986.

4. Salomon DR and Croker BC: Pathology of the Renal Allograft. In: Renal Pathology , edited by CC Tisher and BM Brenner, J.B. Lippincott, pp.1518-1554, 1989.

5. Salomon DR: Proteinuria. In: Nephrology for the Houseofficer , edited by CCTisher and CS Wilcox, Williams and Wilkins, Baltimore, MD, 1989.

6. Salomon DR: Glomerulonephritis. In: Nephrology for the Houseofficer , edited by CC-Tisher and CS Wilcox, Williams and Wilkins, Baltimore, MD, 1989.

7. Salomon DR: Kidney Transplantation. In: Nephrology for the Houseofficer , edited by CCTisher and CS Wilcox, Williams and Wilkins, Baltimore, MD, 1989.

8. Salomon DR and Limacher MC: Chronic Immunosuppression and the Treatment of Acute Rejection. In: Cardiac Transplantation: A Manual for Health Care Professionals, edited by Hosenpud, Cobanuglu, Norman and Starr, Springer-Verlag, New York, NY, 1990.

9. Salomon DR, Sattinger A and Amend WC: Patient Noncompliance and Cyclosporine Drug Interactions in the Long Term Management of Kidney Transplant Patients. Health Sciences Media, Atlanta, GA, 1991.

10. Yee GC and Salomon DR: Cyclosporine. In: Applied Pharmacokinetics:Principles of Therapeutic Drug Monitoring. 3rd edition, edited by WE Evans, JJ Schenpag and WJ Jusko, Applied Therapeutics, Vancouver, WA, pp 28-1 to 28-30, 1992.

11. Salomon DR: Practical Guidelines for the Use of Immunosuppression in Renal Transplantation, Pharmacotherapy, vol. 11, pp 153S-164S, 1991.


12. Salomon DR: The Significance of Cyclosporine Nephrotoxicity and Adequate Immuno-suppression in Long Term Kidney Transplantation. In: Transplantation Reviews, edited by NL Tilney and PJ Morris, WB Saunders Company, Philadelphia, PA, vol. 6, pp 10-19, 1991.

13. Salomon DR: Long Term Subtherapeutic Cyclosporine Dosing Can Lead to Chronic Rejection. Transplantation and Immunology Letter VIII(1), pp 10-11, 1991.

14. Salomon DR: Invited Editorial-Comments on paper: Xenogeneic Transplantation in a Human, Czaplicki et al. Journal of Heart Transplantation, vol. 11, pp 396-397, 1992.

15. Salomon DR: Novel Approaches to Immunosuppression: Peptides, Adhesion Molecules and Tolerance. In: Heart and Lung Transplantation 2000, edited by MP Kaye and JB O'Connell, RG Landes Company, CRC Press, Boca Raton, FL, 1992.

16. Salomon DR: Consulting Editor-Chapter on Immunomodulation, In: AMA Drug Evalulations, 1992.

17. Salomon DR: 1)New Approaches to Immunosuppression: Drugs, Peptides, Adhesion Molecules and Tolerance. 2) Cyclosporine Therapy for Long Term Immunosuppression of Kidney Transplant Patients. 3) Cytomegalovirus and Its Implications for Immunosuppression and Rejection in Transplantation. 4) An Update on IgA Nephropathy. Philippine Journal of Nephrology, July-December, 1992.

18. Salomon DR: The Critical Importance of Maintaining Adequate Immunosuppression in Pediatric Renal Transplant Recipients in Pediatric Renal Transplantation, eds. Tejani AH and Fine RN, John Wiley and Sons Inc., New York, 1994.

19. Kaplan B, Feutren G, Schran H, Mason J, Torley H, Bainbridge C and Salomon DR: Cyclosporine G (OG37-325)-Experimental Results and Clinical Experience in New Immunosuppressive Agents, ed. Prezpiorca L, BioLiterature Inc., Chicago, 1994.

20. Brems J, Brunson M and Salomon DR: Extracorporeal Hepatic Support in Liver Transplantation, In: Liver Transplantation, ed. Klintmalm G, BioLiterature Inc., Chicago, 1995.

21. Salomon DR, Kaplan B, Schran H, Mason J, Torley H, Bainbridge C, and Feutren G. Experimental and Clinical Experience with OG37-325 in Kidney Transplantation in Principles of Drug Design in Transplantation and Autoimmunity, ed. Lieberman R, Raven Press, 1996.

22. Sayegh MH and Salomon DR. Immunobiology and Allograft Destruction in The Transplantation and Replacement of Thoracic Organs, ed. Cooper DKC, Miller L, Patterson A and Nelson D, Kluwer Academic Press, Dordrecht, The Netherlands, 1996.

23. Salomon DR. Adhesion Molecules in Immunoregulation in Adhesion Molecules in Health and Disease, eds. LC Paul and TB Issekutz, Marcel Dekker Inc, New York, Chapter 8: 223-235, 1997.


24. Salomon DR. Rationale and Mechanisms of Immunosuppression, Kidney International, Vol. 51, Suppl. 58: S48-S50, 1997.

25. Salomon DR. Chapter 1 - The Molecular Basis of Transplantation Immunity, in Kidney Transplant Rejection (3rd edition), eds. LC Racusen, Solez K, Burdick JF and Williams MC, Marcel Dekker, Inc., pp 1-31, 1998.

26. Brunson ME and Salomon DR. Prophylaxis and Treatment of Renal Transplant Rejection, Chapter 16.05 in Principles of Nephrology, eds. R Johnson and J Freehally, Mosby International, London, England, Section 16/Chapter 88: pp 88.1-88.10, 1999.

27. Van der Laan L and Salomon DR. Cross-species transmission of porcine endogenous retroviruses in xenotransplantation: A PERVerted reality? In Current Opinion in Organ Transplantation, eds. L Sher and JM Grinyo, vol. 6 (1): 51-58, 2001.

28. Salomon DR. Invited Commentary: The PHS Guideline for Xenotransplantation: Advances and Limitations. Xenotransplantation, vol. 8(2): 86-89, 2001.

29. Salomon DR. Transplantation: Transplantation: The Challenging Road Ahead. FASEB Breakthroughs in Bioscience Series, 2002.

30. Salomon DR. Invited Editorial: The use of protocol kidney transplantation biopsies. American Journal of Kidney Disease, vol. 40(4): 674-677, 2002.

31. Hildbrand P and Salomon DR. Molecular Biology of Transplantation and Xenotransplantation. In Molecular Basis of Cardiovascular Disease, Second Edition, ed. KR Chien, Harcourt, Orlando, FL, Chapter 32:649-666, 2004.

32. Kunicki TJ, Head S and Salomon DR. Platelet receptor structures and polymorphisms. In Methods Molecular Biology, ed. A. Gibbons, 2004; 273:455-78.

33. Kurian SM and Salomon DR. Genomics and Proteomics in Transplantation. In Current Opinion in Organ Transplantation, ed. D. Cramer and L. Sher, Lippincott Williams & Wilkins, London, GB, 2005; 10(3):191-198.

34. Salomon DR. Forward: Transplant Dermatology: Skin Disease in Organ Transplant Recipients, ed. CC. Otley and T. Stasko, Cambridge University Press, London, GB, 2006.

35. Salomon DR. Islet Xenotransplantation. In Islet Transplantation and Beta Cell Replacement Therapy, ed. J. Shapiro and R. Johnson, Marcel Dekker, New York, NY, 2006.

36. Kurian S, Grigoryev Y, Head S, Campbell D, Mondala T and Salomon DR. Applying genomics to organ transplantation medicine in both discovery and validation of biomarkers. International Immunopharmacology 7(14):1948-60. 2007.

37. Salomon DR and Kirk AD. Invited Editorial: AJT’s Response to the NIH Public Access Regulations. American Journal of Transplantation 8 (10):1969, 2008.


Computer Projects

1. Salomon DR and Pickard TJ: Transplantation Clinic Medical Record.Description - We designed, programmed and implemented a PC-based, networked, graphical user interface and data base for the Kidney and Heart Transplant Programs at the University of Florida including direct data linking to the clinical laboratory computer base. This program was in use for the daily management of over 1000 transplant patients from 1989 to 1994 when the program exceeded its original data allocation limits. Note that I left the Institution in 1990. Presented as an exhibit booth by the invitation of the American College of Cardiology, National Meeting, Atlanta, GA, March, 1989.

2. Salomon DR and Shaw M: a) Computer-Videodisc interactive case management study in transplantation; b) Computer animation of the immune response and mechanisms of immunosuppressants. Description - This project was funded by Sandoz Pharmaceuticals and used to train nephrologists and fellows. A videotape of the animation was distributed to US medical school libraries. Health Sciences Media, Atlanta, GA,1990.

3. American Society of Transplant Physicians and American Society of Transplant Surgeons: CenterSpan Project. (Executive Board, Treasurer). Description - We received a $1 million dollar unrestricted educational grant from Hoffman-La Roche to the two Societies. Our objective was to create and manage an integrated Internet project aimed at providing on-line educational opportunities as well as professional discussion groups and clinical research resources for the memberships of the two Societies. 1996-1998

4. Salomon DR and Merion R: CenterSpanL. American Society of Transplant Surgeons.Description – We initiated and co-moderate an internet listserv for transplantation professionals. This has participants from over 50 countries and over 800 members. 1998-present.


Invited Participation in National/International Meetings or Major Lectures:

Program Committee and Session Chair, American Society of Nephrology,Washington,D.C.,December,1987Program Committee and Session Chair, American Society ofTransplant Physicians, Chicago, IL, June,1988Invited Speaker, National Transplant Coordinator Organization, Pittsburgh, PA,May,1988Invited Speaker, Orlando Regional Medical Center, Internal Medicine Update, Orlando, FL,March,1989Program Committee and Session Chair, International Society of Heart Transplantation, Munich, Germany,

April,1989Visiting Professor, Stritch-Loyola School of Medicine, Department of Surgery, Chicago, IL, April,1989Invited Speaker, American Nephrology Nurses Association, Dallas,TX,May,1989Program Committee and Session Chair, American Society of Transplant Physicians,Chicago, IL,June,1989Invited Participant, Sandoz National Advisory Panel, New York City, NY, July,1989Program Committee, American Society of Nephrology, Washington, D.C.,December,1989Organizer and Chairman, Satellite symposium, American Society of Nephrology,Washington, D.C., Management of Immunosuppressive Drugs in Clinical Transplantation, December,1989Invited Participant, Sandoz Roundtable on LongTerm Renal Graft Function, Scottsdale, AZ, February,1990Invited Speaker, Transplantation Update, University of Pennsylvania, Philadelphia,PA, March,1990Invited Participant, NIH Workshop on Clinical Trials of Immunomodulation for Prevention of IDDM,

Bethesda,MD, April,1990Invited Speaker, Renal Transplantation, Medical College of Pennsylvania, Allegheny General Hospital, Pittsburgh,

PA, April,1990Visiting Professor, Orlando Regional Medical Center, Orlando, FL, May,1990Organizer and Chairman, Symposium on the Molecular Basis of Immunosuppression, American Society of

Transplant Physicians Meeting, Chicago, IL,June,1990Invited Speaker, American College of Clinical Pharmacy Annual Meeting, San Francisco, CA, August,1990Invited Speaker, New Immunosuppressive Agents in Transplantation, Atlanta, GA (Vanderbilt University,

Department of Transplantation) October,1990Invited Speaker, Recent Advances and the Role of the Pharmacist in Transplantation, Sandoz Pharmaceuticals,

Morristown, NJ, October,1990Visiting Professor, Transplantation Advances and CyA Nephrotoxicity, University of Kansas, Kansas City, MO,

November,1990Invited Speaker, Dr. Russell Festschrift, Massachusetts General Hospital, Harvard University, Cambridge, MA,

November,1990Program Committee and Symposium Chair, American Society of Nephrology, Washington DC, December, 1990Invited Speaker, Satellite Symposium: Clinical Challenges in Renal Transplantation, American Society of

Nephrology, Washington DC, December, 1990Invited Speaker, Transplantation Grand Rounds, Cleveland Clinic, Cleveland, OH, December, 1990Invited Speaker, Pacific Northwest Transplant Society Meeting, Portland, OR, December,1990Invited Speaker, American Society of Pediatric Nephrology/Society of Pediatric Research, New Orleans, LA,

April,1991Visiting Professor, University of Nebraska and Creighton University, Omaha, NE, May, 1991Visiting Professor, University of Washington, Seattle, WA, August, 1991Invited Speaker, Pacific Presbyterian Medical Center Transplant Program, San Francisco, CA, August,1991Invited Speaker, University of California San Francisco, Transplantation Program, August, 1991Invited Speaker, University of California Irvine, Division of Nephrology, August, 1991Invited Speaker, Stanford University, Division Nephrology, Palo Alto, CA, August, 1991Invited Speaker, South Eastern Organ Procurement Foundation (SEOPF) Tri-Annual Meeting, Scientific Session,

September, 1991Visiting Professor, Temple University, Philadelphia, PA, September, 1991Organizer and Faculty, Multicenter Clinical Transplantation Workshop, Orlando, FL, October, 1991Invited Speaker, New York University Medical Center, Post Graduate Transplant Course, New York City,

November, 1991Faculty, Fellows Conference on Transplantation,(Transplant Program, California Pacific Medical Center), Chicago,

IL, November,1991Visiting Professor, Children's Hospital, Division of Pediatric Nephrology, Buffalo, NY, December, 1991Invited Speaker, Symposium:Current concepts in immunosuppressive therapy in solid organ transplantation,

Beatenberg, Switzerland, January, 1992 Invited Speaker, Sandoz Pharmaceutical Research Institute, Immunology Section, Basle, Switzerland, January, 1992


Visiting Professor, University of Massachusetts, Renal Division, Worcester, MA, March,1992Invited Speaker, Renal Grand Rounds, University of California San Diego, CA, March, 1992Visiting Professor, National Kidney Institute and the Philippine Society of Nephrology, Manila, Philippines,

April, 1992Invited Participant, Sandoz Advisory Panel on New Immunosuppressive Drug Trials, Ft. Lauderdale, FL,

April, 1992Visiting Professor, University of Louisville, Renal Division, Louisville, KY, June, 1992Invited Speaker, North American Transplant Coordinators Annual Course, Tempe, AZ, June, 1992Invited Speaker, North American Pediatric Renal Transplant Cooperative Study - 3rd Annual Workshop, Vancouver,

BC, October, 1992Invited Speaker, Transplantation Symposium, National Kidney Foundation Annual Meeting, Baltimore, MD,

November, 1992Invited Speaker, Immunology for Heart Transplant Physicians, Working Group of Cardiac Transplant Physicians, American College of Cardiology Annual Meeting, New Orleans, LA, November, 1992Visiting Professor, Loyola University Medical Center, Cardiac Transplantation and Immunology Program,

Maywood, IL, December, 1992Visiting Professor, Brazilian Organization of Transplantation, Sao Paolo, Brazil, December, 1992Visiting Professor, Emory University, Transplantation Program, Atlanta, GA, March, 1993Invited Speaker, “Cyclosporine: A decade of experience”; at the International Society of Heart and Lung

Transplantation Meeting, Boca Raton, FL, March, 1993Invited Participant, Murine OKT4a Investigator Meeting, RW Johnson Pharmaceutical Research Institute, Somerset,

NJ, April, 1993Invited Speaker, International Society of Nephrology, Seminar on Toxic Nephropathy, Jerusalem, Israel, June, 1993Invited Speaker, Sandoz Research Institute, Immunology Section, Basel, Switzerland, June, 1993Invited Participant, North American Pediatric Renal Transplantation Consenus Conference, Bethesda, MD,

October, 1993Invited Speaker, Cyclosporine G Symposium at the European Society of Organ Transplantation, Rhodes, Greece,

October, 1993Invited Speaker, Transplantation Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA,

November, 1993Invited Speaker, North American Infectious Disease in Transplantation Symposium, Boston, MA, November, 1993Invited Participant/Consultant, Investigator’s Meeting, Multicenter Photopheresis Trial in Heart Transplantation,

Therakos (Johnson and Johnson), Dallas, TX, December,1993Plenary Speaker, International Society of Heart and Lung Transplantation, Venice, Italy, March, 1994Invited Speaker and Session Chair, National Kidney Foundation, Annual Meeting, Chicago, IL, April, 1994Visiting Professor, University of Colorado, Renal Division, Denver, CO, May, 1994Invited Speaker, W.J Flanigan Renal Conference, Baptist Medical Center, Little Rock, AK, October, 1994Visiting Professor, Organ Transplant Programs, University of Tennessee, Memphis, TN, October, 1994Invited Speaker, Future Directions in Immunosuppression, American Association of Pharmaceutical Scientists,

Annual Meeting, San Diego, CA, November, 1994Visiting Professor, Chinese Dialysis and Transplant Association, Guangzhou, Guangdong, China, December, 1994Visiting Professor, Department of Surgery, National University of Taiwan, Taipei, Taiwan ROC, December, 1994Invited Participant, Food and Drug Administration/Centers for Disease Control, Planning for Consensus on

Xenotransplantation, Bethesda, MD, January, 1995Invited Speaker, 1995 Winter Transplant Conference, University of Colorado, Division of Transplant Surgery,

Breckenridge, CO, March, 1995Visiting Professor, University of Oklahoma Health Sciences Center, Department of Surgery, Transplantation

Division, Oklahoma City, OK, April, 1995Invited Speaker and Participant, “Immunology and Cell Biology: Questions in Xenotransplantation”, Biological

Response Modifiers Advisory Committee, Food and Drug Administration, Washington, DC, April, 1995Invited Speaker, American Society of Transplant Physicians, “New Immunosuppressive Strategies in

Transplantation: From Bench to Bedside”, Chicago, IL, May, 1995Invited Speaker, Sandoz Research Institute, “Integrin and Matrix in Islet and Thymic Development”, Hanover, NJ,

October, 1995Invited Speaker, National Kidney Foundation, CNNT, “Insights into immunosuppression with cyclosporines”, San

Diego, CA, November, 1995Invited Speaker, American Society of Nephrology, “Transplantation resources on the Internet”, San Diego, CA,

November, 1995


Invited Speaker and Session Chair, “Xenotransplantation: Public Health Implications”, Transplantation 2000 and Beyond, Sandoz, Basel, Switzerland, December, 1995

Visiting Professor, XXIII International Congress of Internal Medicine, “Tolerance Mechanisms”, “Chronic Rejection” and “Complications of Immunosuppression”, Manila, Philippines, February, 1996

Invited Speaker, North American Pediatric Renal Transplant Society, 6th annual meeting, “Rationale and Mechanisms of Immunosuppression”, Washington, DC, March, 1996.

Invited Speaker and Session Chair, Transplantation and the Internet (Speaker, Chair) and Xenotransplantation Basic Science Symposium (Chair), American Society of Transplant Physicians, Dallas, TX, May, 1996.

Invited Participant, Workshop on Xenograft Transplantation: Science, Ethics and Public Policy. National Academy of Sciences, Washington, DC, July, 1996.

Invited Speaker, Role of cytokines and adhesion molecules in the immune response; Cell Signalling; and Symposium Overview, First ASTP Symposium for Fellows in Transplantation Medicine, St. Louis, MO, July, 1996.

Invited Speaker, The Internet in Nephrology and Transplantation, NKF Southern California Annual Scientific Plenary Symposium, Long Beach, CA, September, 1996.

Invited Speaker, T Cell Development in the Thymus: Structure and Adhesion, Department of Molecular Biology, San Diego State University, San Diego, CA, October, 1996.

Invited Participant, The First International Conference on Human Development, The Centre for Human Development, Prince Edward Island, Canada, October, 1996.

Chair and Speaker, Are you ready for xenotransplantation? Pro and con debate. NKF Annual Scientific Meeting,New Orleans, LA, December, 1996.

Invited Speaker, Short Course: Internet resources for the Nephrologist, ASN National Meeting, New Orleans, LA, December, 1996.

Invited Speaker, New immunosuppressive drugs, Advanced Course in Nephrology, University of California, San Diego, CA, February, 1997.

Invited Speaker, Clinical status of xenotransplantation, First Annual ASTP Basic Sciences Symposium, Phoenix, AZ, February, 1997.

Invited Speaker and Chair, Integrins and matrix in acute and chronic rejection, 4th InternationalBanff Conference on Allograft Pathology, Banff, Canada, March, 1997.

Invited Speaker, Integrin paradigms in thymic and hematopoietic stem cell development, Johnson and Johnson Pharmaceutical Research Institute, Raritan, NJ, March, 1997.

Invited Speaker, Mechanisms of tolerance induction; and Present and future of xenotransplantation, National Association of Transplant Coordinators (NATCO) symposium, Atlanta, GA, March, 1997.

Invited Speaker, Common themes in Developmental Compartments - Thymus and Bone Marrow, Genetic Therapy Inc., Gaithersberg, MD, May, 1997.

Invited Speaker, Xenotransplantation - Fact or Fiction?, American Society of Transplant Physicians Annual Meeting, Chicago, IL, May, 1997.

Invited Speaker, The Present and Future of Xenotransplantation, International Congress of Nephrology, Sydney, Australia, May, 1997.

Invited Speaker, Integrin Adhesion Molecules in Acute and Chronic Rejection, International Symposium on Acute and Chronic Heart Transplant Rejection, Thun, Switzerland, July, 1997.

Invited Participant and Speaker, NIH/FDA/CDC Conference on Cross-Species Infectivity and Pathogenesis, Bethesda, MD, July, 1997.

Invited Participant and Speaker, Xenomania vs. Xenophobia, Ohio State University, Columbus, OH, September, 1997.

Visiting Professor, Future Directions in Transplantation, 25th Anniversary of Transplantation at La Coruna Hospital, La Coruna, Spain, October, 1997.

Invited Participant, ASTP/ASTS Task Force on Tolerance Induction for Transplantation, Chicago, IL, October, 1997.

Invited Participant and Speaker, Canadian National Forum on Xenotransplantation, Health Canada, Ottawa, CA, November, 1997.

Organizer and Faculty, Basic Immunology Course, Pre-Congress of Asian Society of Transplantation, Manila, Philippines, December, 1997.

Invited Speaker, “Xenotransplantation: Present and future”, “Transplantation in highly sensitized patients”, “Cell biology and immunology of xenotransplantation” and “The challenge of infection in xenotransplantation”. Congress of Asian Society of Transplantation, Manila, Philippines, December, 1997.

Invited Participant and Panelist, Developing US Public Policy in Xenotransplantation, Natcher Center, NIH, Bethesda, MD, January, 1998.


Invited Participant, University of Colorado Transplantation, “Xenotransplantation” and “Internet resources for transplantation”, Breckinridge, CO, March, 1998.

Invited Speaker, International Society of Heart Transplantation, Immunobiology for Clinicians Course, “Adhesion molecules and chemokines in transplantation”, Chicago, IL, April, 1998.

Invited Speaker, Nephrology and Transplantation Course, “Xenotransplantation” and “The structure/function paradigm in immunology and cell biology”, Monterey, CA, April, 1998.

Invited Speaker, American Society of Transplant Physicians Annual Meeting, “Internet resources for transplantation” and “Cell adhesion in transplantation biology”, Chicago, IL, May, 1998.

Visiting Professor, University of Padua, Transplantation and Pathology Departments, Padua, Italy, June, 1998.Invited Speaker, Novartis, “The role of chemokine presentation by matrix in cell migration”, Basel, Switzerland,

June, 1998.Invited Speaker and Session Co-Chair, Xenotransplantation and the future of transplantation, International Society

of Transplantation - Novartis Symposium, Montreal, Canada, July, 1998.Invited Speaker and Participant, NIH - NIAID Council Meeting, Intellectual Property Rights in Science, Bethesda,

MD, September, 1998.Invited Speaker, “Xenotransplantation Risks”, Club de la Transplantation, Abbaye de Vaux Cernay, Paris, France,

October, 1998.Visiting Professor, University of Texas, Galveston, Department of Microbiology and Immunology, Galveston, TX,

November, 1998.Visiting Professor, “Debate: A xenotransplantation clinical trials moratorium is bad medicine, bad science and bad

policy.” University of Bern, Bern, Switzerland, March, 1999.Invited Participant, Banbury Conference on Xenotransplantation Infection Risks. Cold Springs Harbor, NY, May,

1999.Organizer and Chair, Xenotransplantation: Step by step against the challenges. American Society of Transplantation

Meeting, Chicago, IL, May, 1999.Invited Speaker, Xenotransplantation, Association of Clinical Scientists, La Jolla, CA, November, 1999.Visiting Professor, University of Texas, Galveston, Department of Microbiology and Immunology, Galveston, TX,

December, 1999. Visiting Professor, All India Medical Institute, New Delhi, India, February, 2000.Invited Speaker and Participant, International PERV Workshop organized by Imutran and Novartis Pharmaceuticals,

Gaithersberg, MD, February, 2000.Invited Speaker, 8th Annual Meeting, International Herpes Management Forum, Malta, November, 2000.Invited Speaker, Developing Research Ethics Seminar Series: “Special Ethical Concerns in Genetic Research, Gene

Therapy and Xenotransplantation”, The Scripps Research Institute and Scripps Clinic, November, 2000.Invited Speaker, Controversies in Nephrology, University of California at San Diego, “Xenotransplantation”, San

Diego, CA, February, 2001. Invited Speaker, Biotechnology Meeting for PHARMA, “Infectious disease risks in xenotransplantation”, Phoenix,

AZ, April, 2001Television Interview, Frontline Series, Public Broadcasting Corporation and WGBH (Boston), “Organ Farms”,

April, 2001.Invited Speaker, American Society of Transplantation Annual Meeting, “Xenotransplantation”, Chicago, IL, May,

2001.Radio Program Interview, KPBS production: The DNA Files, June, 2001.Faculty and Invited Speaker, International Society of Transplantation, Basic Science Meeting: lectures on DNA

Gene Arrays and on Angiogenesis, Thun, Switzerland, August, 2001. Invited Speaker, AMLI National Meeting, Tissue engineering and angiogenesis in islet transplantation, San Diego,

CA, August, 2001.Invited Speaker, UNOS Region 5 Meeting, What’s new in transplantation, San Diego, CA, September, 2001.Invited Participant, NIH/NIDDK, Workshop: Beta cell biology in the 21st Century, Bethesda, MD, November, 2001.Invited Participant and Speaker, 2nd Cabo Gene Therapy Meeting, Immunobiology of gene therapy, Cabo San Lucas,

Mexico, February, 2002.Television Interview, 60 Minutes New Zealand, Xenotransplantation, May, 2002.Visiting Professor, Presbyterian Hospital of Dallas, Ethics and International Issues in Transplantation, July, 2002.Program Committee, 6th Congress of the International Society for Experimental Microsurgery, San Diego, August,

2002.Invited Participant, FDA/NIH Conference on Porcine Endogenous Retrovirus, Bethesda, MD, October, 2002.Invited Speaker, American Association of Laboratory Animal Sciences, Annual meeting, Xenotransplantation risks,

San Antonio, TX, October, 2002.Invited Speaker, NIH, NIAID, Nonhuman primate transplantation techniques workshop, Bethesda, MD, October,


2002. Invited Speaker, Fundamentals of transplantation immunology, Fujisawa Pharmaceuticals National meeting, San

Diego, CA, November, 2002. Radio Interview, BBC World News, Gene Therapy, Present and Future, December, 2002.Invited Speaker, Islet transplantation 2003, Islet Xenotransplantation, Rancho Mirage, December, 2002.Visiting Professor and Broadhurst Lectureship, Schepens Institute, Harvard Medical School, Boston, MA, February,

2003.Invited Participant, Recombinant DNA Advisory Committee, NIH OBA, Bethesda, MD, February, 2003.Invited Participant, 3rd Cabo Gene Therapy Symposium, Gene therapy and bioterrorism, Cabo San Lucas, Mexico,

February, 2003.Invited Speaker, Functional Genomics in Transplantation, Controversies in Transplantation, University of Colorado,

Breckenridge, CO, March, 2003.Invited Speaker, What is the current state of gene therapy?, Gene Therapies for Hemophilia, Salk Institute, La Jolla,

CA, April, 2003.Invited Speaker, Gene therapy for stem cell transplantation, Recent Advances in Hematopoietic Stem Cell

Transplantation, University of California, San Diego, CA, May, 2003.Invited Participant, The Future of Gene Therapy –Expert Panel, Health Technology Center, San Francisco, CA, July,

2003. Invited Speaker, Levine Symposium, Integrins and ECM in Islet Structure and Development, Los Angeles, CA,

November, 2003.Invited Speaker, Secretary’s Advisory Committee on Xenotransplantation, Update on PERV Research and Risk,

Washington, D.C., February, 2004. Invited Speaker, Medical Grand Rounds, Scripps Green Hospital, Transplantation Genomics, La Jolla, CA,

February, 2004.Invited Speaker and Participant, Controversies in Transplantation, Genomics and Proteomics for Transplantation,

Breckenridge, CO, March, 2004.Invited Speaker, Transplantation Course for Nephrologists, Use of Kidney Function Measurements in

Transplantation, Las Vegas, NV, March, 2004.Invited Speaker, Scripps Cancer Center Retreat, Transplant Tolerance, April 2004Invited Speaker, Affymetrix Users Meeting, Gene expression profiles in kidney transplantation, San Francisco, CA,

May, 2004.Symposium Organizer and Speaker, American Society of Gene Therapy, The nexus of cell transplantation and gene

therapy, Mineapolis, MN, June 2004.Invited Speaker, International Society for Transplant Skin Cancers, Genomics for Transplant Immunosuppression,

San Diego, CA, September 2004.Visiting Professor, UCLA, Transplant Grand Rounds, Genomics for Kidney Transplantation, Los Angeles, CA,

October, 2004.Visiting Professor, Mayo Clinic Jacksonville, Transplant Grand Rounds, Genomics for Kidney Transplantation,

Jacksonville, FL, December, 2004.Visiting Professor, University of Alabama at Birmingham, Transplant Grand Rounds, Genomics for Kidney

Transplantation, Birmingham, AL, December, 2004.Invited Speaker and Participant, Controversies in Transplantation, Genomics for Liver Transplantation and Future

Directions, Breckenridge, CO, March, 2005.Invited Speaker, Spare the Nephron Trial Investigator’s Meeting, Roche Pharma, Las Vegas, NV, March, 2005.Conference Organizer and Speaker, American Society of Gene Therapy Stakeholder’s Conference, Innate Immunity

in Gene Therapy, Washington, D.C., April, 2005.Invited Speaker, Immunology of Immunosuppression, Scripps Transplant Workshop for Nurses, La Jolla, CA, April,

2005. Invited Speaker, Genomics in Transplantation, Advances in Transplant Therapeutics, 9th International Congress on

Therapeutic Drug Monitoring and Clinical Therapeutics, Louisville, KY, April, 2005Visiting Professor, Emory University Medical Center, Transplant Grand Rounds, Atlanta, GA, April, 2005. Invited Speaker, FDA Science Board, Cell Transplantation, Angiogenesis and Tissue Engineering, Washington,

D.C., April, 2005.Course Organizer and Speaker, The nexus of cell transplantation, tissue engineering and gene therapy, American

Society of Transplantation Annual Meeting, Seattle, WA, May, 2005.Invited Speaker, Transplantation Genomics, Affymetrix National Users Meeting, Boston, MA, May, 2005.Invited Speaker/Consultant, Transplantation Genomics, Roche Pharmaceuticals, Palo Alto, CA, June, 2005.Visiting Professor, Transplantation Grand Rounds, University of Southern California, Los Angeles, CA, June, 2005.Invited Participant/Speaker, Transplantation Genomics, Immunosuppression Summit, UCLA, Los Angeles, CA,


June, 2005.Workshop Co-Organizer/Speaker, Genomics in Transplantation, International Banff Conference on Allograft

Nephropathy, Edmonton, Canada, July, 2005.Invited Speaker, Genomics in Liver Transplantation, 6th International Symposium on FAP and Other Transthyretin

Related Disorders and the 5th International Workshop on Liver Transplantation in FAP, The Scripps Research Institute, La Jolla, CA, August, 2005.

Invited Speaker, Translational Research: When to move from Bench to Bedside, American Society of Transplantation Symposium on Clinical Research, Chicago, IL, September, 2005.

Invited Speaker, Future of Treatment for Type I Diabetes, Juvenile Diabetes Research Foundation and Amylin Research Symposium, La Jolla, CA, September, 2005.

Invited Speaker, Genomics for Clinical Transplantation: Diagnosis to Discovery, Thomas Starzl Transplant Fellows Symposium, Scottsdale, AZ, November, 2005.

Invited Speaker and Participant, Transplant Genomics, NIH Clinical Trials in Organ Transplantation (CTOT) Steering Committee meeting, Philadelphia, PA, November, 2005.

Invited Speaker, Genomics in Transplantation, Roche Pharmaceutical Research, Palo Alto, CA, January, 2006.Visiting Professor, Transplantation Research Lecture Series, University of California, San Diego, CA, February,

2006.Invited Speaker and Participant, NIH Bioinformatics Summit, NIAID, Rockville, MD, February, 2006.Visting Professor, Genomics and Proteomics in Transplantation, University of Pennsylvania, Philadelphia, PA,

February, 2006. Visiting Professor, Genomics and Proteomics in Transplantation, University of Alberta, Edmonton, Canada, March,

2006.Visiting Professor, Genomics and Proteomics in Transplantation, Massachusetts General Hospital, Harvard Medical

School, Boston, MA, April, 2006.Member, External Scientific Advisory Panel, NIH P01 HL078819-01, Immune responses to AAV-mediated F.IX

gene transfer, University of Pennsylvania, Philadelphia, PA, May, 2006.Visiting Professor, Genomics and Proteomics in Transplantation, University of Oregon Health Sciences Center,

Portland, OR, May, 2006.Invited Speaker and Symposium Organizer, Innate Immunity in Gene Therapy, American Society of Gene Therapy

Annual Meeting, Baltimore, MD, June, 2006.Invited Speaker and Chair, Genomics in Liver Transplantation, World Transplant Congress, Boston, MA, July,

2006.Organizer, Basic and Clinical Challenges in Islet Transplantation, National Centers for Research Resources,

National Institutes of Health, Islet Cell Resources Consortium, Minneapolis, MN, August, 2006.Invited Plenary Speaker, Genomics and Proteomics in Transplantation, Roche International Experts Meeting,

Valencia, Spain, September, 2006.Visiting Professor, Genomics and Proteomics in Transplantation, Emory University, Atlanta, GA, October, 2006.Invited Plenary Speaker, Genomics and Proteomics in Transplantation, American Society of Histocompatibility and

Immunogenetics Annual Meeting, San Diego, CA, October, 2006.Visiting Professor, Genomics and Proteomics in Transplantation, Mayo Clinic Arizona, Scottsdale, AZ, October,

2006. Visiting Professor, Biomarkers and Discovery in Transplantation, U.S. Food and Drug Administration, Centers for

Drug Review, Silver Spring, MD, October, 2006.Invited Plenary Speaker, Gene expression profiling of human islet cells, Rachmeil Levine Diabetes Symposium,

Long Beach, CA, November, 2006.Visiting Professor, Genomics and Proteomics in Transplantation, University of Maryland, Baltimore, MD,

December, 2006.Invited Speaker, Transplantation Service, Genomics and Proteomics for Transplantation, University of Washington,

Seattle, WA, January, 2007.Visiting Professor, Genomics and Proteomics for Transplantation, University of Florida, Gainesville, FL, February,

2007.Invited Speaker, Ethics Lecture Series – The Black Market in Organ Transplantation and the White Market in Organ

Donation, University of California, San Diego, CA, March, 2007.Visiting Professor, Alpha Omega Alpha Society and Stritch Loyola School of Medicine, Surgical Grand Rounds on

Genomics and Proteomics for Transplantation and Basic Science Lecture on Porcine Endogenous Retrovirus and Risk in Xenotransplantation, Maywood, IL, March, 2007.

Visiting Professor, Lecture on Transplantation Genomics and Proteomics, Medical College of Wisconsin, Milwaukee, WI, April, 2007.

Invited Plenary Speaker, Genomics and Proteomics in Transplantation, Annual Meeting, International Society of Daniel R. Salomon, M.D. version: April 13, 2023 page 29

Heart and Lung Transplantation, San Francisco, CA, April, 2007. Invited Speaker, Impact of Diabetes and Malignancy After Kidney Transplantation, Annual Nephrology Forum,

Kaiser Permante, Southern California, Annaheim, CA, May, 2007.Invited Speaker and Chair, Integrating Genomics and Proteomics in Transplantation, Symposium on Genomics and

Genetics, American Transplant Congress, San Francisco, CA, May, 2007. Invited Speaker and Co-organizer, Banff Conference on Genomics in Transplantation, Edmonton, CA, June, 2007.Invited Speaker, Biomarkers for Rejection/Tolerance in Transplantation, Advances in Transplantation, La Jolla, CA,

September, 2007.Visiting Professor, Genomics and Proteomics in Transplantation and Medicine, International Symposium on Heart

Transplantation, Juan Peron Hospital, Formosa Argentina, September, 2007.Invited Speaker, Biomarkers for Kidney Transplantation, Transplantation Summit, Chicago, IL, September, 2007.Invited Speaker/Program Committee, Rachmiel Levine Symposium, Genomic Biomarkers for Islet Transplantation,

Newport Beach, CA, January, 2008. Visiting Professor, Genomics and Proteomics in Transplantation, Israeli Transplantation Society, Herzelea, Israel,

January, 2008.Invited Speaker, Translational Research, Graduate Training Day, Canadian Society of Transplantation, Mt.

Tremblant, Quebec, Canada, February, 2008. Invited Speaker, Suren Seghal Memorial Lecture, Canadian Society of Transplantation, Mt. Tremblant, Quebec,

Canada, February, 2008. Visiting Professor, Genomics and Proteomics in Transplantation, Northwestern University, Chicago, IL, March,

2008.Invited Expert, FDA Advisory Panel, Devising Regulations for Embryonic Stem Cell Transplantation, Gaithersberg,

MD, April, 2008.Invited Speaker, American Society of Nephrology, Pediatrics Section, Biomarkers in Kidney Transplantation,

Honolulu, HI, May, 2008.Visiting Professor, Proteogenomics in Transplantation, Medical University of South Carolina, Charleston, SC,

September, 2008.Visiting Professor, Proteogenomics in Transplantation, Medical Grand Rounds, Northwestern University, Chicago,

IL, November, 2008.Organizer and Speaker, 2nd Scripps-NIH Symposium on Genomics in Transplantation, The Scripps Research

Institute, La Jolla, CA, January, 2009.


Click here for Dr. Salomon's Curriculum Vitae

Documents

transplantation boston

scripps research institute

scripps center

cell transplantation

research fellow

il medicine

transplantation immunology1984

university of florida